Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

The Role of Quality Assurance in Driving Biotech Innovation

Feb 03, 2025

The Importance of Quality Assurance in Biotech

In the rapidly evolving field of biotechnology, innovation is the cornerstone of progress. However, the path from groundbreaking research to market-ready products is fraught with challenges. This is where Quality Assurance (QA) plays a pivotal role. By ensuring that products meet rigorous standards, QA not only safeguards public health but also accelerates the development process.

Quality assurance in biotech involves a comprehensive set of activities designed to guarantee that products are safe, effective, and of high quality. From the early stages of research and development through to manufacturing and distribution, QA provides a structured framework to minimize risks and ensure compliance with regulatory requirements.

quality assurance biotech

Ensuring Compliance and Safety

The biotech industry is heavily regulated, given the potential impact of its products on human health and the environment. Compliance with these regulations is non-negotiable. QA teams work diligently to ensure that every aspect of the development process adheres to established standards, thereby preventing costly delays or product recalls.

Safety is paramount in biotech. QA processes are designed to identify and mitigate risks at every stage, from laboratory testing to clinical trials. By implementing robust quality control measures, companies can detect potential issues early, ensuring that only safe and effective products reach the market.

biotech lab safety

Enhancing Product Reliability and Efficiency

Beyond compliance and safety, QA contributes significantly to product reliability and efficiency. Through meticulous testing and validation processes, QA ensures that products perform consistently as intended. This reliability is crucial in building trust with consumers and stakeholders alike.

Efficiency is another critical aspect where QA adds value. By streamlining processes and eliminating inefficiencies, QA helps reduce time-to-market for new products. This accelerated pace of innovation allows biotech companies to remain competitive in a fast-paced industry.

biotech efficiency

Facilitating Continuous Improvement

Quality assurance is not a static process; it facilitates continuous improvement within organizations. By analyzing data and feedback from various stages of development, QA teams can identify areas for improvement and implement changes accordingly. This iterative approach fosters innovation by encouraging the adoption of new technologies and methodologies.

Moreover, continuous improvement practices help companies stay ahead of evolving regulatory landscapes. By proactively adapting to new standards and requirements, biotech firms can maintain their competitive edge while ensuring ongoing compliance.

The Strategic Role of Quality Assurance

The strategic role of QA extends beyond technical aspects; it also encompasses organizational culture. A strong quality culture fosters collaboration across departments, encouraging teams to prioritize quality in every decision they make. This cultural shift can drive innovation by embedding quality into the core of business operations.

Quality assurance professionals act as catalysts for innovation, bridging the gap between research and commercialization. By aligning quality objectives with business goals, QA enables companies to achieve sustainable growth while delivering innovative solutions to meet global challenges.

quality culture biotech

Conclusion: The Future of QA in Biotech

As the biotech sector continues to evolve, the role of quality assurance will become increasingly vital. Future advancements in technology and science will present new opportunities and challenges for QA professionals. Embracing digital transformation, such as through automation and artificial intelligence, will further enhance QA processes, driving efficiency and precision.

In conclusion, quality assurance is a cornerstone of biotech innovation. By ensuring safety, reliability, and compliance, while fostering a culture of continuous improvement, QA paves the way for groundbreaking advancements that have the potential to transform lives worldwide.